PUMA BIOTECHNOLOGY, INC.
PBYI
13 insider filings · Latest: Jul 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Jan 3 1:30 AM | AUERBACH ALAN H | Proposed Sale | 33,841 | $3.05 | $103.2K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Feb 21 1:29 AM | Alan H AuerbachDirector, President and CEO, 10% Owner | Grant/Award | 227,474 | $6.68 | 227,474(D) | View → |
| Feb 18, 2026 | Feb 21 1:28 AM | Douglas M HuntThe Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | Grant/Award | 70,321 | $6.68 | 70,321(D) | View → |
| Feb 18, 2026 | Feb 21 1:28 AM | Maximo F NouguesChief Financial Officer | Grant/Award | 66,541 | $6.68 | 66,541(D) | View → |